MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific DPO Ratio 2011-2026 | TMO
Annual DPO Ratio Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 49.3 | 43.7 | 45.4 | 34.1 | 32.6 | 31.9 | 33.4 | 32.5 | 33.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.3 | 31.9 | 37.3 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
50.1 | $ 114.78 | -0.61 % | $ 34.9 B |  USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.15 | -0.83 % | $ 4.94 M | USA |
 |
BioNano Genomics
BNGO
|
149 | $ 1.16 | -3.33 % | $ 6.32 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 16.33 | 0.8 % | $ 176 M |  China |
 |
CareDx, Inc
CDNA
|
44.2 | $ 18.12 | -1.04 % | $ 966 M | USA |
 |
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 166.88 | -4.03 % | $ 8.27 B | USA |
 |
Castle Biosciences
CSTL
|
52 | $ 25.0 | 0.64 % | $ 694 M | USA |
 |
Danaher Corporation
DHR
|
65.4 | $ 191.23 | 0.06 % | $ 136 B | USA |
 |
DexCom
DXCM
|
67.7 | $ 63.01 | 1.26 % | $ 24.6 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 16.56 | -1.55 % | $ 501 M | USA |
 |
Guardant Health
GH
|
48.6 | $ 90.84 | -3.19 % | $ 11.4 B | USA |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 111.1 | -2.71 % | $ 9.16 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.92 | -1.92 % | $ 8.49 M | USA |
 |
Illumina
ILMN
|
56.3 | $ 126.95 | -0.34 % | $ 20.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
IQVIA Holdings
IQV
|
126 | $ 169.58 | -2.12 % | $ 29.2 B | USA |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 274.35 | 0.23 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 75.67 | -0.57 % | $ 5.11 B | USA |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 494.14 | -0.84 % | $ 14.3 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 256.28 | -0.29 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.76 | 0.11 % | $ 441 M | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
ENDRA Life Sciences
NDRA
|
1.65 K | $ 4.57 | -2.46 % | $ 3.6 M | USA |
 |
NeoGenomics
NEO
|
19.7 | $ 7.98 | -0.25 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 9.51 | 1.01 % | $ 2.06 B | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 17.43 | 1.6 % | $ 390 M | USA |
 |
Natera
NTRA
|
17.9 | $ 204.77 | -1.54 % | $ 20.2 B | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | $ 1.41 | 5.05 % | $ 423 M | USA |
 |
Precipio
PRPO
|
23.9 | $ 26.84 | 5.67 % | $ 43.1 M | USA |
 |
Personalis
PSNL
|
67.3 | $ 6.64 | 0.84 % | $ 393 M | USA |
 |
RadNet
RDNT
|
23.5 | $ 55.13 | 0.62 % | $ 4.15 B | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |